Paroxetine
Depression, Bipolar
Aalborg University HospitalSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Depression, Bipolar cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olanzapine China Medical University, China | Phase 4 | BBB |
ZIPRASIDONE Queen's University | Phase 4 | BBB |
Valproic Acid Ewha Womans University Mokdong Hospital | Phase 4 | BB |
Cariprazine Aalborg University Hospital | Phase 4 | BB |
Starch China Medical University, China | Phase 4 | BB |
View all 23 →
Same molecule, other indications
Paroxetine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →